These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35456526)

  • 21. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
    Marchetti O; Moreillon P; Entenza JM; Vouillamoz J; Glauser MP; Bille J; Sanglard D
    Antimicrob Agents Chemother; 2003 May; 47(5):1565-70. PubMed ID: 12709323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of novel synthetic dodecapeptides against Candida albicans.
    Maurya IK; Thota CK; Sharma J; Tupe SG; Chaudhary P; Singh MK; Thakur IS; Deshpande M; Prasad R; Chauhan VS
    Biochim Biophys Acta; 2013 Nov; 1830(11):5193-203. PubMed ID: 23876294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Perea S; López-Ribot JL; Wickes BL; Kirkpatrick WR; Dib OP; Bachmann SP; Keller SM; Martinez M; Patterson TF
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-Activity Fluoroquinolone-Transportan 10 Conjugates Offer Alternative Leukemia Therapy during Hematopoietic Cell Transplantation.
    Lica JJ; Heldt M; Wieczór M; Chodnicki P; Ptaszyńska N; Maciejewska N; Łęgowska A; Brankiewicz W; Gucwa K; Stupak A; Pradhan B; Gitlin-Domagalska A; Dębowski D; Milewski S; Bieniaszewska M; Grabe GJ; Hellmann A; Rolka K
    Mol Pharmacol; 2023 Dec; 105(1):39-53. PubMed ID: 37977824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
    Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
    Mansfield BE; Oltean HN; Oliver BG; Hoot SJ; Leyde SE; Hedstrom L; White TC
    PLoS Pathog; 2010 Sep; 6(9):e1001126. PubMed ID: 20941354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antifungal effects of curcumin derivatives as fungal biofilm inhibitors with fluconazole.
    Dong HH; Wang YH; Peng XM; Zhou HY; Zhao F; Jiang YY; Zhang DZ; Jin YS
    Chem Biol Drug Des; 2021 May; 97(5):1079-1088. PubMed ID: 33506609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y; Ren H; Wang D; Zhang M; Sun S; Zhao Y
    Biomed Pharmacother; 2020 Oct; 130():110580. PubMed ID: 32745913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida.
    Meleddu R; Distinto S; Corona A; Maccioni E; Arridu A; Melis C; Bianco G; Matyus P; Cottiglia F; Sanna A; De Logu A
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1672-7. PubMed ID: 26745285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans.
    Mahmoud DE; Faraag AHI; Abu El-Wafa WM
    World J Microbiol Biotechnol; 2021 Oct; 37(11):191. PubMed ID: 34632522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species.
    Zhang J; Liu W; Tan J; Sun Y; Wan Z; Li R
    Mycopathologia; 2013 Apr; 175(3-4):273-9. PubMed ID: 23341047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
    Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W; Zhang H; Li C; Li G; Liu X; Wei J
    BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against
    Chen X; Shi Y; Li Y; Su S; Wang P; Sun S
    Expert Rev Anti Infect Ther; 2021 Jan; 19(1):109-115. PubMed ID: 32924656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
    Magill SS; Shields C; Sears CL; Choti M; Merz WG
    J Clin Microbiol; 2006 Feb; 44(2):529-35. PubMed ID: 16455909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant
    Li L; Zhang T; Xu J; Wu J; Wang Y; Qiu X; Zhang Y; Hou W; Yan L; An M; Jiang Y
    Front Microbiol; 2019; 10():2071. PubMed ID: 31555252
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates.
    Ahmad A; Khan A; Khan LA; Manzoor N
    J Med Microbiol; 2010 Oct; 59(Pt 10):1178-1184. PubMed ID: 20634332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.